# Predictive Value of Preoperative Dynamic Contrast-Enhanced MRI Imaging Features in Breast Cancer Patients with Postoperative Recurrence Time.

> **Reliability concern:** This paper was retracted on 2024-01-24. See notice: 10.1155/2024/9870248.

- **DOI:** [10.1155/2022/9556880](https://doi.org/10.1155/2022/9556880)
- **Rating:** Limited (2.3 out of 5)
- **Verdict:** Exploratory DCE-MRI recurrence-timing study undermined by a recurrent-only sample design that inflates apparent predictive performance.
- **Framework version:** v5.0
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-05-21
- **Evaluation page:** https://www.nabu.science/paper/10.1155%2F2022%2F9556880

## Strengths

- **Clinically relevant question with structured imaging assessment** The study addresses the practical clinical problem of predicting breast cancer recurrence timing using standardized DCE-MRI with both morphological and hemodynamic parameters measured via Omni-Kinetics software, providing a systematic multi-feature assessment.
  - Dimension: contribution
  - Location: Introduction; Section 2.4
- **Survival analysis adds prognostic context** The Kaplan-Meier analysis with log-rank test (P=0.012) demonstrates that early recurrence is associated with worse survival outcomes (median 26.8 vs. 54.3 months), providing clinically meaningful context for the imaging findings.
  - Dimension: methodological rigour
  - Location: Section 3.5
- **Quantitative ROC outputs with sensitivity and specificity** The paper reports concrete quantitative metrics including AUC with 95% confidence intervals and sensitivity/specificity at a specified cutoff, enabling comparison with future studies even if the current performance estimates require external validation.
  - Dimension: methodological rigour
  - Location: Section 3.4; Table 3

## Limitations

- **Recurrent-only sample inflates apparent predictive performance** All 86 patients had confirmed postoperative recurrence — no non-recurrent comparator group is included. The ROC analysis (AUC 0.918) is computed within this restricted population, dramatically inflating discriminative performance compared to what would be observed in a general breast cancer population where the clinically relevant question is who will recur.
  - Dimension: methodological rigour
  - Location: Section 2.1; Section 3.4
- **No confounding adjustment for key prognostic factors** The two groups are compared on DCE-MRI features without controlling for tumor stage, grade, or receptor status (ER/PR/HER2) — all known determinants of both recurrence timing and imaging features. No baseline characteristics table stratified by recurrence group is presented.
  - Dimension: methodological rigour
  - Location: Methods Sections 2.4–2.6
- **Internal reporting errors undermine confidence** Section 2.1 states '66 patients were divided' but the subgroups sum to 86. Section 3.1 reports 'no significant differences' with '(P < 0.05)', directly contradicting the Discussion which correctly states P > 0.05. These errors suggest insufficient quality control in manuscript preparation.
  - Dimension: reporting
  - Location: Section 2.1; Section 3.1; Section 4 (Discussion)

## Reliability checks

Concerns (4 of 4 checks).

- **Internal coherence:** Noted. The paper contains a numerical inconsistency (Section 2.1 states '66 patients' but subgroup totals sum to 86) and a logical contradiction in statistical reporting (Section 3.1 reports 'no significant differences' with 'P < 0.05', contradicted by the Discussion which correctly states P > 0.05). Additionally, the ROC analysis (Section 3.4) does not specify which variable or combination of variables produced the reported AUC of 0.918.
- **Research conduct:** Noted. No ethics approval or informed consent statement is present in the paper, which is a reporting omission for a retrospective clinical study by 2020 standards. No conflict of interest disclosure is provided. The data availability statement is vague, offering data 'without undue reservation' but naming no repository or persistent identifier.
- **Reference integrity:** Clean. All 14 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Concern
- **Summary:** This paper was retracted on 2024-01-24. See notice: 10.1155/2024/9870248.
- **Last checked:** 2026-10-17
